Evaluation of Blood Gas Syringes

Post-Market Study Evaluating Analyzer Readings of Multiple Arterial Blood Gas Syringes

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01935284

Acronym

Analyze ABS

Enrollment

Registered

2013-09-05

Start date

2013-06-30

Completion date

2013-06-30

Last updated

2013-09-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Blood Gas Analyte Values

Brief summary

To assess the interchangeability and agreement between measurements from three blood gas syringes for the collection of blood for the analysis of multiple analytes as measured by differing manufacturers' multi-parameter analyzers.

Detailed description

This is a prospective, randomized, post-market study using fresh blood for analysis that is obtained from healthy subject volunteers. Trained phlebotomists will collect blood samples from subjects after confirmation of eligibility criteria. Blood samples will be drawn to fill all study syringe types in a randomized order. Each syringe type will be drawn per subject to analyze each of the available blood parameters in duplicate using three different multi-parameter analyzers. The analytes tested will vary per analyzer capabilities. All blood draws and analyte testing will be performed at an independent laboratory. The study is to confirm that all of the syringes tested provide consistent readings when analyzed using the most common multi-parameter analyzers used in hospital laboratories.

Interventions

None listed

Study design

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

1. 18 years of age or older 2. Willing and able to independently sign an English Informed Consent 3. Have adequate veins for sampling blood from both right and left upper extremities

Exclusion criteria

1. Currently taking anti-coagulation medication 2. Have a known bloodborne disease or bleeding tendency 3. Have a known fear or adverse reaction to needles or blood 4. Women who are pregnant or nursing

Design outcomes

Primary

Measure	Time frame	Description
Differences in analyte values obtained from three different blood gas syringes for each analyzer tested	Blood analysis within 30 minutes of draw	For each of the analytes that are tested, the analyte values from each of the three (3) syringe types tested will be compared for each of the three (3) multi-parameter analyzers. Average values for each analyte per patient, syringe and analyzer will be used for the comparison of syringes for each analyzer.

Countries

United States

Outcome results